Recent Quotes (30 days)

You have no recent quotes
chg | %
BNTC1.24-0.068-5.22%
OCUL5.51-0.255-4.43%
PTX0.550-0.055-9.07%
NEO9.16+0.2352.63%
HSGX1.98-0.030-1.50%
EVOK10.26+0.6406.65%
STXS1.18-0.082-6.50%
EBIO2.49-0.030-1.19%
ECTE1.480.000.00%
AMGN162.03+1.851.16%
GILD86.70+0.4500.52%
JNJ122.99+0.0600.05%
CDXS4.27+0.1202.89%
MNOV7.22-0.050-0.69%
FOLD5.910.000.00%
SGNT21.63-0.020-0.09%
BKD16.74+0.0150.09%
TROV5.12+0.2605.35%
CPHD34.35+0.9502.84%
SRPT22.06+0.6903.23%

Rewalk Robotics Ltd  

(Public, NASDAQ:RWLK)   Watch this stock  
Find more results for RWLK
6.91
+0.11 (1.62%)
Real-time:   1:58PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 6.75 - 7.19
52 week 5.55 - 17.40
Open 6.91
Vol / Avg. 32,507.00/82,887.00
Mkt cap 93.22M
P/E     -
Div/yield     -
EPS -2.18
Shares 12.37M
Beta     -
Inst. own 32%
Aug 4, 2016
Q2 2016 Rewalk Robotics Ltd Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jun 9, 2016
Rewalk Robotics Ltd at Jefferies Healthcare Conference
May 24, 2016
Rewalk Robotics Ltd Annual Shareholders Meeting
May 22, 2016
Rewalk Robotics Ltd Other Corporate
May 21, 2016
Rewalk Robotics Ltd at Oppenheimer Israeli Conference
May 5, 2016
Q1 2016 Rewalk Robotics Ltd Earnings Release
May 5, 2016
Q1 2016 Rewalk Robotics Ltd Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -335.86% -678.46%
Operating margin -311.26% -672.02%
EBITD margin - -660.33%
Return on average assets -97.98% -69.40%
Return on average equity -150.75% -78.47%
Employees 87 -
CDP Score - -

Address

3 Hatnufa st. 6th fl., P.O. Box 161
YOKNEAM, 2069203
Israel
+972-4-9590123 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement. The Company's ReWalk designs focus on people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, who have the use of their upper bodies and arms. The Company offers various products, which include ReWalk Personal and ReWalk Rehabilitation. The Company's ReWalk Personal is designed for use by individuals at home and in their communities, and is custom-fit for each user. The Company's ReWalk Rehabilitation is designed for the clinical rehabilitation environment where it provides exercise and therapy.

Officers and directors

Kevin W. Hershberger Chief Financial Officer
Age: 49
Bio & Compensation  - Reuters
John Hamilton Vice President - Regulatory and Clinical
Age: 60
Bio & Compensation  - Reuters
Ofir Koren Vice President - Research & Development
Age: 44
Bio & Compensation  - Reuters
Jodi Gricci Vice President - Global Marketing
Age: 47
Bio & Compensation  - Reuters
Miri Pariente Global Director - Quality
Age: 37
Bio & Compensation  - Reuters
Ori Schellas Director of Operations
Age: 38
Bio & Compensation  - Reuters
Jeff Dykan Independent Chairman of the Board
Age: 56
Bio & Compensation  - Reuters
Larry Jasinski Chief Executive Officer, Director
Age: 57
Bio & Compensation  - Reuters
Aryeh Dan Director
Age: 55
Bio & Compensation  - Reuters
Deborah DiSanzo Director
Age: 55
Bio & Compensation  - Reuters